web builder

For Patients

Our team of pharmacists, nurses and patient advocates work with you and your physicians to ensure you receive the optimal treatment plan that best fits you and your infusion needs. We guide and educate you throughout the entire process to ensure you understand the risks, benefits, insurance requirements. Here are some Frequently Asked Questions:


Your doctor may tell you that you need infusion therapy. Infusion therapy is prescribed when oral medications will not work. Drug therapies commonly administered intravenously include immunoglobulin (Ig), infliximab, natalizumab, blood factors, biologics, corticosteroids, erythropoietin, vitamin therapies, and many others.

IVIg (intravenous immunoglobulin) is an infusion therapy for many disease states. It is the name for antibodies that come from donated human plasma, which provides healthy antibodies to block the immune and inflammatory processes. Currently, IVIg therapy is FDA approved for the treatment of primary immunodeficiency, autoimmune thrombocytopenia, Kawasaki disease, hematopoietic stem cell or bone marrow transplantation (in patients older than two), chronic B-cell lymphocytic leukemia, prevention of certain diseases in transplant patients, pediatric HIV-1 infection, chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). IVIg therapy is also used “off-label” in the treatment of: aplastic anemia, MS, RA, small fiber neuropathy, polyneuropathy, dermatomyositis, red blood cell aplasia, autoimmune hemolytic anemia, patients with acquired clotting factor inhibitors, acquired von Willebrand disease, immune-mediated neutropenia.

Many diseases can be treated with infusion therapy. These include neuropathic pain, CIDP, myasthenia gravis, multiple sclerosis, rheumatoid arthritis, autoimmune disorders, primary immunodeficiency conditions, secondary immunodeficiency in chronic lymphocytic leukemia, cancer related pain, Kawasaki disease, prevention of graft disease or rejection in transplants, Guillain-Barre syndrome, respiratory illnesses, blood diseases such as hemophilia, dermatological diseases, Lyme disease and Crohn’s disease, among many others.

Many patients can receive their IV therapies at home. Often times, a nurse will administer the therapy while the patient is in the comfort of their own home. A thorough patient and home assessment are conducted to make sure the patient is a good candidate for home care.

Some patients, for personal, insurance or therapy-related reasons, receive their treatments at ambulatory infusion suites. This care is cost effective, and many members of your medical team are on site. Axiva is opening suites in locations across the country. The first two sites are opening in the Greater Philadelphia area (Havertown, PA and Huntingdon Valley, PA) in February 2019.

Each patient’s insurance is different, so call us (1-844-44-AXIVA) and we help you navigate your insurance.

More online resources for patients:
National Home Infusion Association: www.nhia.com
Myasthenia Gravis Foundation of America: www.myasthenia.org
Muscular Dystrophy Association: www.mda.org
American AutoImmune Related Diseases Association: www.aarda.org

Contact Us - Info@Axiva.com
© Copyright 2018 Axiva Health Solutions - All Rights Reserved